Cosmos Health Inc., a diversified global healthcare group, has announced a new purchase order for 80,000 units of its Sky Premium Life products from Pharmalink in the United Arab Emirates $(UAE)$. This follows the successful sell-out of an initial 130,000-unit order and aligns with the company's five-year goal of surpassing 3 million units in cumulative orders. Greg Siokas, CEO of Cosmos Health, expressed enthusiasm over the strong momentum of Sky Premium Life nutraceuticals in the UAE, crediting the effective partnership with Pharmalink for capturing significant market share in the high-growth region. Pharmalink will manage sales, marketing, regulatory affairs, logistics, and distribution for the products in the UAE.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。